Bicycle Therapeutics Plc - ADR

BCYC

Market Cap$479.78M

Close$

Compare Bicycle Therapeutics Plc - ADR

	P/E Ratio	Dividends	Return on Equity	Price-to-Sales	Debt-to-Equity
Bicycle Therapeutics Plc - ADR	-2.7	0%	-49%	22.7	0.1
Market Avg	58.9	1.29%	29%	-	1
Healthcare Avg	66.3	1.31%	15%	-	0.9

$-23.31

Current Fair Value

202.5% downside

Overvalued by 202.5% based on the discounted cash flow analysis.

Share Statistics

Market cap	$479.78 Million
Enterprise Value	$-6,558,881.00
Dividend Yield	$0.0 (0.0%)
Earnings per Share	$-5.08
Beta	0.0
Outstanding Shares	21,304,801
Avg 30 Day Volume	424,494

Return

Return on Equity	-
Return on Assets	-
Return on Invested Capital	-

Valuation & Multiples

P/E Ratio	-2.66
PEG	-4.16
Price to Sales	22.73
Price to Book Ratio	1.34
Enterprise Value to Revenue	-0.24
Enterprise Value to EBIT	0.03
Enterprise Value to Net Income	0
Total Debt to Enterprise	-6.11
Debt to Equity	0.11

Revenue Sources

No data

ESG Score

No data

About Bicycle Therapeutics Plc

CEO: Kevin Lee